Welcome to our dedicated page for Orthopedia news (Ticker: KIDS), a resource for investors and traders seeking the latest updates and insights on Orthopedia stock.
Orthopedia (KIDS) is a medical device innovator focused exclusively on pediatric orthopedic solutions, developing specialized implants and surgical instruments for children's unique anatomical needs. This dedicated news hub provides investors, analysts, and healthcare professionals with centralized access to official company announcements and developments.
Find timely updates on financial earnings, product launches, regulatory milestones, and strategic partnerships that demonstrate Orthopedia's leadership in pediatric care innovation. Each press release and news article is curated to deliver actionable insights into the company's operational progress and market positioning.
As a vital resource for tracking advancements in children's orthopedic healthcare, this page offers verified information to support informed decision-making. Bookmark this hub or check back regularly for essential updates directly impacting the evolving landscape of pediatric medical technology.
OrthoPediatrics Corp. (KIDS) announced the launch of its RESPONSE 5.5/6.0 Cannulated Screw System, enhancing its RESPONSE™ Scoliosis portfolio. This marks the company's 47th surgical system, reinforcing its commitment to pediatric orthopedic innovation. The system features instruments and implants designed to improve screw placement accuracy and efficiency in surgeries. Early feedback from surgeons has been overwhelmingly positive, highlighting the system's effectiveness for the S1AI screw placement technique. The new product reflects OrthoPediatrics' dedication to advancing pediatric orthopedic solutions and its global reach in serving over 70 countries.
OrthoPediatrics Corp. (NASDAQ: KIDS) announced the upcoming release of its first quarter 2023 financial results on May 1, 2023, after market close. A conference call will be held on May 2, 2023, at 8:00 a.m. ET to discuss these results. The company, founded in 2006, specializes in pediatric orthopedics and currently offers 47 surgical systems targeting trauma, deformity, scoliosis, and sports medicine. OrthoPediatrics operates globally, distributing its products in the U.S. and over 70 additional countries. Investors can access the conference call via a live and archived webcast on the company's website.
OrthoPediatrics Corp. (Nasdaq: KIDS) will have its President & CEO, Dave Bailey, and COO & CFO, Fred Hite, participate in a fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on April 17, 2023, at 8:45 am ET. This event highlights the company's dedication to pediatric orthopedics, having developed the most comprehensive product offerings in this field. Founded in 2006, OrthoPediatrics markets 47 surgical systems across trauma, scoliosis, and sports medicine, serving the U.S. and over 70 countries globally. An audio webcast will be available at their investor relations site, with a replay following the event.
FAQ
What is the current stock price of Orthopedia (KIDS)?
What is the market cap of Orthopedia (KIDS)?
